Product NDC: | 0615-5575 |
Proprietary Name: | Torsemide |
Non Proprietary Name: | Torsemide |
Active Ingredient(s): | 20 mg/1 & nbsp; Torsemide |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0615-5575 |
Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076346 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110719 |
Package NDC: | 0615-5575-31 |
Package Description: | 31 TABLET in 1 BLISTER PACK (0615-5575-31) |
NDC Code | 0615-5575-31 |
Proprietary Name | Torsemide |
Package Description | 31 TABLET in 1 BLISTER PACK (0615-5575-31) |
Product NDC | 0615-5575 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Torsemide |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110719 |
Marketing Category Name | ANDA |
Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
Substance Name | TORSEMIDE |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC] |